To protect patient safety, organizations must use insulated packaging that keeps medications within the labeled temperature range, ensure chain-of-custody, and manage risks like delays, temperature fluctuations, or improper handling in transit
In December 2014, the Food and Drug Administration (FDA) approved liraglutide for weight loss, and semaglutide was approved for diabetes in 2017 and obesity in 2021, opening a new era of obesity treatment
No se trata de la prdida de peso, se trata del mantenimiento
Both suppress mesolimbic reward circuits, reducing the hedonic drive to eat
This fundamental difference distinguishes peptide therapy from conventional pharmaceutical approaches
Regain weight remains an issue and tends to pile straight back on after patients stop taking the medication according to one study of 1961 patients in the Diabetes, Obesity and Metabolism journal